Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Platinum-based Anticancer Drugs Market Insights, Forecast to 2030

Global Platinum-based Anticancer Drugs Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-04-07

Pages: 118 Pages

Report ld: 2826577

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Platinum-based Anticancer Drugs market is projected to grow from US$ 1579.1 million in 2024 to US$ 1788.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.1% during the forecast period.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Platinum-based Anticancer Drugs Market Size

M= millions and B=billions

Report Covers:
This report presents an overview of global market for Platinum-based Anticancer Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Platinum-based Anticancer Drugs, also provides the sales of main regions and countries. of the upcoming market potential for Platinum-based Anticancer Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Platinum-based Anticancer Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Platinum-based Anticancer Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Platinum-based Anticancer Drugs sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Report Metric
Details
Report Title
Global Platinum-based Anticancer Drugs Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 1788.9 million
CAGR(2024-2030)
2.1%
Market Size Available for Years
2019-2030
Global Platinum-based Anticancer Drugs Companies Covered
Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira(Pfizer), Mylan, Taj Pharmaceuticals, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Luoxin, Lingnan Pharmacy, Hansoh Pharma
Global Platinum-based Anticancer Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Platinum-based Anticancer Drugs Market, Segment by Type
Cisplatin

Carboplatin

Oxaliplatin

Nedaplatin

Others
Global Platinum-based Anticancer Drugs Market, Segment by Application
Testicular Cancer

Osteosarcoma

Breast Cancer

Esophageal Cancer

NSCLC

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Platinum-based Anticancer Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Platinum-based Anticancer Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Platinum-based Anticancer Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Platinum-based Anticancer Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Cisplatin
        1.2.3 Carboplatin
        1.2.4 Oxaliplatin
        1.2.5 Nedaplatin
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Testicular Cancer
        1.3.3 Osteosarcoma
        1.3.4 Breast Cancer
        1.3.5 Esophageal Cancer
        1.3.6 NSCLC
        1.3.7 Other
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Platinum-based Anticancer Drugs Sales Estimates and Forecasts 2019-2030
    2.2 Global Platinum-based Anticancer Drugs Revenue by Region
        2.2.1 Global Platinum-based Anticancer Drugs Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Platinum-based Anticancer Drugs Revenue by Region (2019-2024)
        2.2.3 Global Platinum-based Anticancer Drugs Revenue by Region (2025-2030)
        2.2.4 Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2019-2030)
    2.3 Global Platinum-based Anticancer Drugs Sales Estimates and Forecasts 2019-2030
    2.4 Global Platinum-based Anticancer Drugs Sales by Region
        2.4.1 Global Platinum-based Anticancer Drugs Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Platinum-based Anticancer Drugs Sales by Region (2019-2024)
        2.4.3 Global Platinum-based Anticancer Drugs Sales by Region (2025-2030)
        2.4.4 Global Platinum-based Anticancer Drugs Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Platinum-based Anticancer Drugs Sales by Manufacturers
        3.1.1 Global Platinum-based Anticancer Drugs Sales by Manufacturers (2019-2024)
        3.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Platinum-based Anticancer Drugs in 2023
    3.2 Global Platinum-based Anticancer Drugs Revenue by Manufacturers
        3.2.1 Global Platinum-based Anticancer Drugs Revenue by Manufacturers (2019-2024)
        3.2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Platinum-based Anticancer Drugs Revenue in 2023
    3.3 Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    3.4 Global Platinum-based Anticancer Drugs Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Offered and Application
    3.8 Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Platinum-based Anticancer Drugs Sales by Type
        4.1.1 Global Platinum-based Anticancer Drugs Historical Sales by Type (2019-2024)
        4.1.2 Global Platinum-based Anticancer Drugs Forecasted Sales by Type (2025-2030)
        4.1.3 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    4.2 Global Platinum-based Anticancer Drugs Revenue by Type
        4.2.1 Global Platinum-based Anticancer Drugs Historical Revenue by Type (2019-2024)
        4.2.2 Global Platinum-based Anticancer Drugs Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    4.3 Global Platinum-based Anticancer Drugs Price by Type
        4.3.1 Global Platinum-based Anticancer Drugs Price by Type (2019-2024)
        4.3.2 Global Platinum-based Anticancer Drugs Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Platinum-based Anticancer Drugs Sales by Application
        5.1.1 Global Platinum-based Anticancer Drugs Historical Sales by Application (2019-2024)
        5.1.2 Global Platinum-based Anticancer Drugs Forecasted Sales by Application (2025-2030)
        5.1.3 Global Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    5.2 Global Platinum-based Anticancer Drugs Revenue by Application
        5.2.1 Global Platinum-based Anticancer Drugs Historical Revenue by Application (2019-2024)
        5.2.2 Global Platinum-based Anticancer Drugs Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    5.3 Global Platinum-based Anticancer Drugs Price by Application
        5.3.1 Global Platinum-based Anticancer Drugs Price by Application (2019-2024)
        5.3.2 Global Platinum-based Anticancer Drugs Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Platinum-based Anticancer Drugs Market Size by Type
        6.1.1 US & Canada Platinum-based Anticancer Drugs Sales by Type (2019-2030)
        6.1.2 US & Canada Platinum-based Anticancer Drugs Revenue by Type (2019-2030)
    6.2 US & Canada Platinum-based Anticancer Drugs Market Size by Application
        6.2.1 US & Canada Platinum-based Anticancer Drugs Sales by Application (2019-2030)
        6.2.2 US & Canada Platinum-based Anticancer Drugs Revenue by Application (2019-2030)
    6.3 US & Canada Platinum-based Anticancer Drugs Market Size by Country
        6.3.1 US & Canada Platinum-based Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Platinum-based Anticancer Drugs Sales by Country (2019-2030)
        6.3.3 US & Canada Platinum-based Anticancer Drugs Revenue by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Platinum-based Anticancer Drugs Market Size by Type
        7.1.1 Europe Platinum-based Anticancer Drugs Sales by Type (2019-2030)
        7.1.2 Europe Platinum-based Anticancer Drugs Revenue by Type (2019-2030)
    7.2 Europe Platinum-based Anticancer Drugs Market Size by Application
        7.2.1 Europe Platinum-based Anticancer Drugs Sales by Application (2019-2030)
        7.2.2 Europe Platinum-based Anticancer Drugs Revenue by Application (2019-2030)
    7.3 Europe Platinum-based Anticancer Drugs Market Size by Country
        7.3.1 Europe Platinum-based Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Platinum-based Anticancer Drugs Sales by Country (2019-2030)
        7.3.3 Europe Platinum-based Anticancer Drugs Revenue by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Platinum-based Anticancer Drugs Market Size
        8.1.1 China Platinum-based Anticancer Drugs Sales  (2019-2030)
        8.1.2 China Platinum-based Anticancer Drugs Revenue  (2019-2030)
    8.2 China Platinum-based Anticancer Drugs Market Size by Application
        8.2.1 China Platinum-based Anticancer Drugs Sales by Application (2019-2030)
        8.2.2 China Platinum-based Anticancer Drugs Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Platinum-based Anticancer Drugs Market Size by Type
        9.1.1 Asia Platinum-based Anticancer Drugs Sales by Type (2019-2030)
        9.1.2 Asia Platinum-based Anticancer Drugs Revenue by Type (2019-2030)
    9.2 Asia Platinum-based Anticancer Drugs Market Size by Application
        9.2.1 Asia Platinum-based Anticancer Drugs Sales by Application (2019-2030)
        9.2.2 Asia Platinum-based Anticancer Drugs Revenue by Application (2019-2030)
    9.3 Asia Platinum-based Anticancer Drugs Sales by Region
        9.3.1 Asia Platinum-based Anticancer Drugs Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Platinum-based Anticancer Drugs Revenue by Region (2019-2030)
        9.3.3 Asia Platinum-based Anticancer Drugs Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Market Size by Type
        10.1.1 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Market Size by Application
        10.2.1 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Country
        10.3.1 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 Sanofi-Aventis
        11.1.1 Sanofi-Aventis Company Information
        11.1.2 Sanofi-Aventis Overview
        11.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 Sanofi-Aventis Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi-Aventis Recent Developments
    11.2 Yakult honsha
        11.2.1 Yakult honsha Company Information
        11.2.2 Yakult honsha Overview
        11.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Yakult honsha Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Yakult honsha Recent Developments
    11.3 Dr Reddy's laboratories
        11.3.1 Dr Reddy's laboratories Company Information
        11.3.2 Dr Reddy's laboratories Overview
        11.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Dr Reddy's laboratories Recent Developments
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Company Information
        11.4.2 Sun Pharmaceutical Overview
        11.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sun Pharmaceutical Recent Developments
    11.5 Teva
        11.5.1 Teva Company Information
        11.5.2 Teva Overview
        11.5.3 Teva Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 Teva Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Teva Recent Developments
    11.6 Fresenius Kabi
        11.6.1 Fresenius Kabi Company Information
        11.6.2 Fresenius Kabi Overview
        11.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 Fresenius Kabi Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Fresenius Kabi Recent Developments
    11.7 Hospira(Pfizer)
        11.7.1 Hospira(Pfizer) Company Information
        11.7.2 Hospira(Pfizer) Overview
        11.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hospira(Pfizer) Recent Developments
    11.8 Mylan
        11.8.1 Mylan Company Information
        11.8.2 Mylan Overview
        11.8.3 Mylan Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 Mylan Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Mylan Recent Developments
    11.9 Taj Pharmaceuticals
        11.9.1 Taj Pharmaceuticals Company Information
        11.9.2 Taj Pharmaceuticals Overview
        11.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Taj Pharmaceuticals Recent Developments
    11.10 Jiangsu Hengrui Medicine
        11.10.1 Jiangsu Hengrui Medicine Company Information
        11.10.2 Jiangsu Hengrui Medicine Overview
        11.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.10.4 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Jiangsu Hengrui Medicine Recent Developments
    11.11 Nanjing Pharmaceutical Factory
        11.11.1 Nanjing Pharmaceutical Factory Company Information
        11.11.2 Nanjing Pharmaceutical Factory Overview
        11.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.11.4 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Nanjing Pharmaceutical Factory Recent Developments
    11.12 Jiangsu Aosaikang Pharmaceutical
        11.12.1 Jiangsu Aosaikang Pharmaceutical Company Information
        11.12.2 Jiangsu Aosaikang Pharmaceutical Overview
        11.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.12.4 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
    11.13 Qilu Pharmaceutical
        11.13.1 Qilu Pharmaceutical Company Information
        11.13.2 Qilu Pharmaceutical Overview
        11.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.13.4 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Qilu Pharmaceutical Recent Developments
    11.14 Hisun Pharmaceutical
        11.14.1 Hisun Pharmaceutical Company Information
        11.14.2 Hisun Pharmaceutical Overview
        11.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.14.4 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Hisun Pharmaceutical Recent Developments
    11.15 Luoxin
        11.15.1 Luoxin Company Information
        11.15.2 Luoxin Overview
        11.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.15.4 Luoxin Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Luoxin Recent Developments
    11.16 Lingnan Pharmacy
        11.16.1 Lingnan Pharmacy Company Information
        11.16.2 Lingnan Pharmacy Overview
        11.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.16.4 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Lingnan Pharmacy Recent Developments
    11.17 Hansoh Pharma
        11.17.1 Hansoh Pharma Company Information
        11.17.2 Hansoh Pharma Overview
        11.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
        11.17.4 Hansoh Pharma Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Hansoh Pharma Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Platinum-based Anticancer Drugs Industry Chain Analysis
    12.2 Platinum-based Anticancer Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Platinum-based Anticancer Drugs Production Mode & Process
    12.4 Platinum-based Anticancer Drugs Sales and Marketing
        12.4.1 Platinum-based Anticancer Drugs Sales Channels
        12.4.2 Platinum-based Anticancer Drugs Distributors
    12.5 Platinum-based Anticancer Drugs Customers

 13 Market Dynamics
    13.1 Platinum-based Anticancer Drugs Industry Trends
    13.2 Platinum-based Anticancer Drugs Market Drivers
    13.3 Platinum-based Anticancer Drugs Market Challenges
    13.4 Platinum-based Anticancer Drugs Market Restraints

 14 Key Findings in The Global Platinum-based Anticancer Drugs Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Cisplatin
    Table 3. Major Manufacturers of Carboplatin
    Table 4. Major Manufacturers of Oxaliplatin
    Table 5. Major Manufacturers of Nedaplatin
    Table 6. Major Manufacturers of Others
    Table 7. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Platinum-based Anticancer Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Platinum-based Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Platinum-based Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 11. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2019-2024)
    Table 12. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2025-2030)
    Table 13. Global Platinum-based Anticancer Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Platinum-based Anticancer Drugs Sales by Region (2019-2024) & (MT)
    Table 15. Global Platinum-based Anticancer Drugs Sales by Region (2025-2030) & (MT)
    Table 16. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2019-2024)
    Table 17. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2025-2030)
    Table 18. Global Platinum-based Anticancer Drugs Sales by Manufacturers (2019-2024) & (MT)
    Table 19. Global Platinum-based Anticancer Drugs Sales Share by Manufacturers (2019-2024)
    Table 20. Global Platinum-based Anticancer Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 21. Global Platinum-based Anticancer Drugs Revenue Share by Manufacturers (2019-2024)
    Table 22. Global Key Players of Platinum-based Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 23. Platinum-based Anticancer Drugs Price by Manufacturers 2019-2024 (US$/MT)
    Table 24. Global Platinum-based Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Platinum-based Anticancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2023)
    Table 26. Global Key Manufacturers of Platinum-based Anticancer Drugs, Manufacturing Base Distribution and Headquarters
    Table 27. Global Key Manufacturers of Platinum-based Anticancer Drugs, Product Offered and Application
    Table 28. Global Key Manufacturers of Platinum-based Anticancer Drugs, Date of Enter into This Industry
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Platinum-based Anticancer Drugs Sales by Type (2019-2024) & (MT)
    Table 31. Global Platinum-based Anticancer Drugs Sales by Type (2025-2030) & (MT)
    Table 32. Global Platinum-based Anticancer Drugs Sales Share by Type (2019-2024)
    Table 33. Global Platinum-based Anticancer Drugs Sales Share by Type (2025-2030)
    Table 34. Global Platinum-based Anticancer Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 35. Global Platinum-based Anticancer Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 36. Global Platinum-based Anticancer Drugs Revenue Share by Type (2019-2024)
    Table 37. Global Platinum-based Anticancer Drugs Revenue Share by Type (2025-2030)
    Table 38. Platinum-based Anticancer Drugs Price by Type (2019-2024) & (US$/MT)
    Table 39. Global Platinum-based Anticancer Drugs Price Forecast by Type (2025-2030) & (US$/MT)
    Table 40. Global Platinum-based Anticancer Drugs Sales by Application (2019-2024) & (MT)
    Table 41. Global Platinum-based Anticancer Drugs Sales by Application (2025-2030) & (MT)
    Table 42. Global Platinum-based Anticancer Drugs Sales Share by Application (2019-2024)
    Table 43. Global Platinum-based Anticancer Drugs Sales Share by Application (2025-2030)
    Table 44. Global Platinum-based Anticancer Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 45. Global Platinum-based Anticancer Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 46. Global Platinum-based Anticancer Drugs Revenue Share by Application (2019-2024)
    Table 47. Global Platinum-based Anticancer Drugs Revenue Share by Application (2025-2030)
    Table 48. Platinum-based Anticancer Drugs Price by Application (2019-2024) & (US$/MT)
    Table 49. Global Platinum-based Anticancer Drugs Price Forecast by Application (2025-2030) & (US$/MT)
    Table 50. US & Canada Platinum-based Anticancer Drugs Sales by Type (2019-2024) & (MT)
    Table 51. US & Canada Platinum-based Anticancer Drugs Sales by Type (2025-2030) & (MT)
    Table 52. US & Canada Platinum-based Anticancer Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 53. US & Canada Platinum-based Anticancer Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 54. US & Canada Platinum-based Anticancer Drugs Sales by Application (2019-2024) & (MT)
    Table 55. US & Canada Platinum-based Anticancer Drugs Sales by Application (2025-2030) & (MT)
    Table 56. US & Canada Platinum-based Anticancer Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 57. US & Canada Platinum-based Anticancer Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 58. US & Canada Platinum-based Anticancer Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 59. US & Canada Platinum-based Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 60. US & Canada Platinum-based Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 61. US & Canada Platinum-based Anticancer Drugs Sales by Country (2019-2024) & (MT)
    Table 62. US & Canada Platinum-based Anticancer Drugs Sales by Country (2025-2030) & (MT)
    Table 63. Europe Platinum-based Anticancer Drugs Sales by Type (2019-2024) & (MT)
    Table 64. Europe Platinum-based Anticancer Drugs Sales by Type (2025-2030) & (MT)
    Table 65. Europe Platinum-based Anticancer Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 66. Europe Platinum-based Anticancer Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 67. Europe Platinum-based Anticancer Drugs Sales by Application (2019-2024) & (MT)
    Table 68. Europe Platinum-based Anticancer Drugs Sales by Application (2025-2030) & (MT)
    Table 69. Europe Platinum-based Anticancer Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 70. Europe Platinum-based Anticancer Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 71. Europe Platinum-based Anticancer Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 72. Europe Platinum-based Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 73. Europe Platinum-based Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 74. Europe Platinum-based Anticancer Drugs Sales by Country (2019-2024) & (MT)
    Table 75. Europe Platinum-based Anticancer Drugs Sales by Country (2025-2030) & (MT)
    Table 76. China Platinum-based Anticancer Drugs Sales by Type (2019-2024) & (MT)
    Table 77. China Platinum-based Anticancer Drugs Sales by Type (2025-2030) & (MT)
    Table 78. China Platinum-based Anticancer Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 79. China Platinum-based Anticancer Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 80. China Platinum-based Anticancer Drugs Sales by Application (2019-2024) & (MT)
    Table 81. China Platinum-based Anticancer Drugs Sales by Application (2025-2030) & (MT)
    Table 82. China Platinum-based Anticancer Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 83. China Platinum-based Anticancer Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 84. Asia Platinum-based Anticancer Drugs Sales by Type (2019-2024) & (MT)
    Table 85. Asia Platinum-based Anticancer Drugs Sales by Type (2025-2030) & (MT)
    Table 86. Asia Platinum-based Anticancer Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 87. Asia Platinum-based Anticancer Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 88. Asia Platinum-based Anticancer Drugs Sales by Application (2019-2024) & (MT)
    Table 89. Asia Platinum-based Anticancer Drugs Sales by Application (2025-2030) & (MT)
    Table 90. Asia Platinum-based Anticancer Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 91. Asia Platinum-based Anticancer Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 92. Asia Platinum-based Anticancer Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 93. Asia Platinum-based Anticancer Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 94. Asia Platinum-based Anticancer Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 95. Asia Platinum-based Anticancer Drugs Sales by Region (2019-2024) & (MT)
    Table 96. Asia Platinum-based Anticancer Drugs Sales by Region (2025-2030) & (MT)
    Table 97. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Type (2019-2024) & (MT)
    Table 98. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Type (2025-2030) & (MT)
    Table 99. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Application (2019-2024) & (MT)
    Table 102. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Application (2025-2030) & (MT)
    Table 103. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 106. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Country (2019-2024) & (MT)
    Table 109. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales by Country (2025-2030) & (MT)
    Table 110. Sanofi-Aventis Company Information
    Table 111. Sanofi-Aventis Description and Major Businesses
    Table 112. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 113. Sanofi-Aventis Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Sanofi-Aventis Recent Developments
    Table 115. Yakult honsha Company Information
    Table 116. Yakult honsha Description and Major Businesses
    Table 117. Yakult honsha Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 118. Yakult honsha Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Yakult honsha Recent Developments
    Table 120. Dr Reddy's laboratories Company Information
    Table 121. Dr Reddy's laboratories Description and Major Businesses
    Table 122. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 123. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Dr Reddy's laboratories Recent Developments
    Table 125. Sun Pharmaceutical Company Information
    Table 126. Sun Pharmaceutical Description and Major Businesses
    Table 127. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 128. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Sun Pharmaceutical Recent Developments
    Table 130. Teva Company Information
    Table 131. Teva Description and Major Businesses
    Table 132. Teva Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 133. Teva Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Teva Recent Developments
    Table 135. Fresenius Kabi Company Information
    Table 136. Fresenius Kabi Description and Major Businesses
    Table 137. Fresenius Kabi Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 138. Fresenius Kabi Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Fresenius Kabi Recent Developments
    Table 140. Hospira(Pfizer) Company Information
    Table 141. Hospira(Pfizer) Description and Major Businesses
    Table 142. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 143. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Hospira(Pfizer) Recent Developments
    Table 145. Mylan Company Information
    Table 146. Mylan Description and Major Businesses
    Table 147. Mylan Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 148. Mylan Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Mylan Recent Developments
    Table 150. Taj Pharmaceuticals Company Information
    Table 151. Taj Pharmaceuticals Description and Major Businesses
    Table 152. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 153. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Taj Pharmaceuticals Recent Developments
    Table 155. Jiangsu Hengrui Medicine Company Information
    Table 156. Jiangsu Hengrui Medicine Description and Major Businesses
    Table 157. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 158. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Jiangsu Hengrui Medicine Recent Developments
    Table 160. Nanjing Pharmaceutical Factory Company Information
    Table 161. Nanjing Pharmaceutical Factory Description and Major Businesses
    Table 162. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 163. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Nanjing Pharmaceutical Factory Recent Developments
    Table 165. Jiangsu Aosaikang Pharmaceutical Company Information
    Table 166. Jiangsu Aosaikang Pharmaceutical Description and Major Businesses
    Table 167. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 168. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Jiangsu Aosaikang Pharmaceutical Recent Developments
    Table 170. Qilu Pharmaceutical Company Information
    Table 171. Qilu Pharmaceutical Description and Major Businesses
    Table 172. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 173. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Qilu Pharmaceutical Recent Developments
    Table 175. Hisun Pharmaceutical Company Information
    Table 176. Hisun Pharmaceutical Description and Major Businesses
    Table 177. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 178. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Hisun Pharmaceutical Recent Developments
    Table 180. Luoxin Company Information
    Table 181. Luoxin Description and Major Businesses
    Table 182. Luoxin Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 183. Luoxin Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. Luoxin Recent Developments
    Table 185. Lingnan Pharmacy Company Information
    Table 186. Lingnan Pharmacy Description and Major Businesses
    Table 187. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 188. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Lingnan Pharmacy Recent Developments
    Table 190. Hansoh Pharma Company Information
    Table 191. Hansoh Pharma Description and Major Businesses
    Table 192. Hansoh Pharma Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 193. Hansoh Pharma Platinum-based Anticancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 194. Hansoh Pharma Recent Developments
    Table 195. Key Raw Materials Lists
    Table 196. Raw Materials Key Suppliers Lists
    Table 197. Platinum-based Anticancer Drugs Distributors List
    Table 198. Platinum-based Anticancer Drugs Customers List
    Table 199. Platinum-based Anticancer Drugs Market Trends
    Table 200. Platinum-based Anticancer Drugs Market Drivers
    Table 201. Platinum-based Anticancer Drugs Market Challenges
    Table 202. Platinum-based Anticancer Drugs Market Restraints
    Table 203. Research Programs/Design for This Report
    Table 204. Key Data Information from Secondary Sources
    Table 205. Key Data Information from Primary Sources
List of Figures
    Figure 1. Platinum-based Anticancer Drugs Product Picture
    Figure 2. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Platinum-based Anticancer Drugs Market Share by Type in 2023 & 2030
    Figure 4. Cisplatin Product Picture
    Figure 5. Carboplatin Product Picture
    Figure 6. Oxaliplatin Product Picture
    Figure 7. Nedaplatin Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Platinum-based Anticancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Platinum-based Anticancer Drugs Market Share by Application in 2023 & 2030
    Figure 11. Testicular Cancer
    Figure 12. Osteosarcoma
    Figure 13. Breast Cancer
    Figure 14. Esophageal Cancer
    Figure 15. NSCLC
    Figure 16. Other
    Figure 17. Platinum-based Anticancer Drugs Report Years Considered
    Figure 18. Global Platinum-based Anticancer Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Platinum-based Anticancer Drugs Revenue 2019-2030 (US$ Million)
    Figure 20. Global Platinum-based Anticancer Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 21. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2019-2030)
    Figure 22. Global Platinum-based Anticancer Drugs Sales 2019-2030 ((MT)
    Figure 23. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2019-2030)
    Figure 24. US & Canada Platinum-based Anticancer Drugs Sales YoY (2019-2030) & (MT)
    Figure 25. US & Canada Platinum-based Anticancer Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Platinum-based Anticancer Drugs Sales YoY (2019-2030) & (MT)
    Figure 27. Europe Platinum-based Anticancer Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. China Platinum-based Anticancer Drugs Sales YoY (2019-2030) & (MT)
    Figure 29. China Platinum-based Anticancer Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Asia (excluding China) Platinum-based Anticancer Drugs Sales YoY (2019-2030) & (MT)
    Figure 31. Asia (excluding China) Platinum-based Anticancer Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales YoY (2019-2030) & (MT)
    Figure 33. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 34. The Platinum-based Anticancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 35. The Top 5 and 10 Largest Manufacturers of Platinum-based Anticancer Drugs in the World: Market Share by Platinum-based Anticancer Drugs Revenue in 2023
    Figure 36. Global Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 37. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    Figure 38. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    Figure 39. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    Figure 40. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    Figure 42. US & Canada Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    Figure 43. US & Canada Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    Figure 44. US & Canada Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    Figure 45. US & Canada Platinum-based Anticancer Drugs Revenue Share by Country (2019-2030)
    Figure 46. US & Canada Platinum-based Anticancer Drugs Sales Share by Country (2019-2030)
    Figure 47. U.S. Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 48. Canada Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 49. Europe Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    Figure 50. Europe Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    Figure 51. Europe Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    Figure 52. Europe Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    Figure 53. Europe Platinum-based Anticancer Drugs Revenue Share by Country (2019-2030)
    Figure 54. Europe Platinum-based Anticancer Drugs Sales Share by Country (2019-2030)
    Figure 55. Germany Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 56. France Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 57. U.K. Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 58. Italy Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 59. Russia Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 60. China Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    Figure 61. China Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    Figure 62. China Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    Figure 63. China Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    Figure 65. Asia Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    Figure 66. Asia Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    Figure 67. Asia Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    Figure 68. Asia Platinum-based Anticancer Drugs Revenue Share by Region (2019-2030)
    Figure 69. Asia Platinum-based Anticancer Drugs Sales Share by Region (2019-2030)
    Figure 70. Japan Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 71. South Korea Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 72. China Taiwan Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 73. Southeast Asia Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 74. India Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 75. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales Market Share by Type (2019-2030)
    Figure 76. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue Market Share by Type (2019-2030)
    Figure 77. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales Market Share by Application (2019-2030)
    Figure 78. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue Market Share by Application (2019-2030)
    Figure 79. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Revenue Share by Country (2019-2030)
    Figure 80. Middle East, Africa and Latin America Platinum-based Anticancer Drugs Sales Share by Country (2019-2030)
    Figure 81. Brazil Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 82. Mexico Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 83. Turkey Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 84. Israel Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 85. GCC Countries Platinum-based Anticancer Drugs Revenue (2019-2030) & (US$ Million)
    Figure 86. Platinum-based Anticancer Drugs Value Chain
    Figure 87. Platinum-based Anticancer Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed

Description

The global Platinum-based Anticancer Drugs market is projected to grow from US$ 1579.1 million in 2024 to US$ 1788.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.1% during the forecast period.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Market Segmentation